Qube Research & Technologies (QRT)
BPTH

Qube Research & Technologies (QRT)’s Bio-Path Holdings Inc BPTH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$200 – 4384
2024
Q2 		$200 Buy
+100
New +$274 ﹤0.01% 3392

Other funds holding BPTH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BPTH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Bio-Path Holdings Inc (BPTH) in Q3 2024, closing a stake of 100 shares — an estimated $200 sold.

Qube Research & Technologies (QRT) first reported a position in BPTH in Q2 2024 and held it in 1 quarter. The position peaked at $200 in Q2 2024. 14 funds tracked by Wall St. Rank hold BPTH as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Bio-Path Holdings Inc position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 100 Bio-Path Holdings Inc shares in Q3 2024, an estimated $200.
  • Qube Research & Technologies (QRT) first reported a position in Bio-Path Holdings Inc in Q2 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Bio-Path Holdings Inc position peaked at $200 in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.